link ae888

HCM City: 24 percent of TB cases are drug-resistant

About 24 percent of tuberculosis (TB) patients in Ho Chi Minh City show symptoms of drug or multi-drug resistance, heard a conference on December 29.
HCM City: 24 percent of TB cases are drug-resistant ảnh 1About 24 percent of tuberculosis (TB) patients in Ho Chi Minh City show symptoms of drug or multi-drug resistance. (Source: VNA)

HCM City (VNA) – About 24 percent of tuberculosis(TB) patients in Ho Chi Minh City show symptoms of drug or multi-drugresistance, heard a conference on December 29, which overviewed TB preventionand treatment in Ho Chi Minh City throughout 2017.

The city recorded 16,452 TB patients in 2017. The rate of TBcases in the city was 196 in every 100,000 residents on average, much higherthan the national average of 110/100,000.

Doctor Dang Minh Duong from the Pham Ngoc Thach Hospitalattributed the drug resistance to the patients’ neglect and failure to completetreatment courses, which often leads to more severe health conditions. He said ittakes between three and six months for TB to show symptoms.

He pointed to the fact that many hold wrong perception of tuberculosis.They think only poor people or those with weak immune system contract thedisease, thus fail to take prompt preventive measures or adhere to treatmentregime, Duong added.

Also in 2017, 282 local children were diagnosedwith tuberculosis.-VNA
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

Forum spotlight𝔉s AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

Vietnam, France collaborate in vaccine production technology tr꧂ansfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{dagathomo tructiep hôm nay}|{link link link ae888}|{dá gà thomo}|{trực tiếp đá gà thomo hom nay}|{sbobet asian handicap}|